Mattiq today announced the appointment of Duane Dickson as Chief Commercial Officer (CCO). Duane’s decades of experience and vast...
Read more
Linnaeus Therapeutics, Inc. continues to push boundaries in oncology with promising new data on LNS8801. Presented at the 2024...
Read more
Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation...
Read more
Actuate Therapeutics, Inc. (NASDAQ: ACTU) announced that it will present at the H.C. Wainwright 26th Annual Global Investment Conference taking...
Read more
Provivi and Syngenta Biologicals today announced a collaboration to develop and commercialize new pheromone-based biological solutions to effectively and...
Read more
With the rising demand for real-time data processing, CXL is emerging as a key innovation for modern data centers,...
Read more
Actuate Therapeutics, Inc., rang the Nasdaq opening bell in celebration of their IPO. This marks the start of an...
Read more
The South Jersey company developing new cancer therapies based on the discoveries of a Penn researcher, Linnaeus Therapeutics, has...
Read more
Sienza Energy, a Caltech-incubated battery company that is backed by Los Angeles-based philanthropist Patrick Soon-Shiong, demonstrates how its unique and proprietary...
Read more
Actuate Therapeutics, Inc. (Nasdaq: ACTU), a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high...
Read more